Bioimpedance as a tool for fluid management in peritoneal dialysis patients

ISRCTN ISRCTN95439739
DOI https://doi.org/10.1186/ISRCTN95439739
ClinicalTrials.gov number NCT00801112
Secondary identifying numbers N/A
Submission date
29/11/2008
Registration date
18/12/2009
Last edited
11/01/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Simon Davies
Scientific

Nephrology Department
University Hospital of North Staffordshire
Princes Road
Hartshill
Stoke on Trent
ST4 7LN
United Kingdom

Email simondavies1@compuserve.com

Study information

Study designMulti-centre randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeOther
Participant information sheet Not available in web format, please use contact details to request a patient information sheet
Scientific titleDeveloping bioimpedance as a tool for fluid management in peritoneal dialysis patients: a validation study
Study objectivesRegular monitoring of bioimpedance (BIA) adds value to the management of fluid status in peritoneal dialysis (PD) patients.
Ethics approval(s)North Staffordshire Local Research Ethics Committee -– submission pending as of 29/11/2008
Health condition(s) or problem(s) studiedEnd stage renal disease on peritoneal dialysis
InterventionClinician to use whatever tools at their disposal to achieve dry weight in PD patients including restricted dietary salt and fluid intake, increased use of hypertonic PD solutions and modality change. BIA to track fluid status changes. BIA measurements will also be taken for the control group but the results will not be acted upon

BIA measurements for all patients will be taken at 3 months intervals. The total duration of the intervention is 1 year.
Intervention typeOther
Primary outcome measureExtra-cellular fluid volume (ECFv) determined from BIA
Secondary outcome measuresOutcomes will be measured at 6-month intervals:
1. Blood pressure control (clinic)
2. Residual urine volume:
2.1. Development of anuria (<200 ml/day)
2.2. Time to halving of urine volume at randomisation
3. Membrane function:
3.1. Glucose exposure
3.2. Solute transport
3.3. Ultrafiltration (UF) capacity
3.4. Free water transport (limited centres, own resources)
4. Cardiac function:
4.1. Brain natriuretic peptide (BNP) (all centres)
4.2. Echocardiography (ECHO) (limited centres, own resources)
5. Fluid status using gold standard methods (limited centres, own resources)
Overall study start date15/01/2009
Completion date15/11/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants100
Key inclusion criteria1. All PD patients who are clinically stable
2. Age >16 years
Key exclusion criteria1. Patients planning discontinuation of PD within 6 months
2. Patients who are unable to give consent
3. Patients who have peritonitis the last 30 days prior to study enrollment
4. Patients who are pregnant
Date of first enrolment15/01/2009
Date of final enrolment15/11/2011

Locations

Countries of recruitment

  • England
  • Italy
  • Netherlands
  • Spain
  • Sweden
  • United Kingdom

Study participating centre

University Hospital of North Staffordshire
Stoke on Trent
ST4 7LN
United Kingdom

Sponsor information

University Hospital of North Staffordshire (UK)
Government

Princes Road
Hartshill
Stoke on Trent
ST4 7LN
United Kingdom

Email darren.clement@uhns.nhs.uk
Website http://www.uhns.nhs.uk

Funders

Funder type

Industry

Baxter (UK) - Clinical Evidence Council

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/2016 Yes No

Editorial Notes

11/01/2017: Publication reference added.